Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 46 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).CompletedNCT03562819
- The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior ChemotherapyCompletedNCT03559647
- A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLCStatus unknownNCT03557411Phase 2
- Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448CompletedNCT03556436Phase 1
- An Expanded Access Program for AM0010 (Pegilodecakin)No longer availableNCT03554434
- Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor InvestigationTerminatedNCT03553550
- Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLCStatus unknownNCT03553485Not applicable
- QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.CompletedNCT03552718Phase 1
- Oncoxin® and Quality of Life in Cancer PatientsCompletedNCT03550482Phase 4
- CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung CancerActive, not recruitingNCT03546361Phase 1
- Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLCCompletedNCT03543683Phase 2
- Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)Status unknownNCT03542461Phase 3
- Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerActive, not recruitingNCT03539536Phase 2
- Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLCCompletedNCT03535363Phase 1
- A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung CancerStatus unknownNCT03533127Phase 3
- Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)Status unknownNCT03532698
- Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating MutationsWithdrawnNCT03529084Phase 3
- Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLCStatus unknownNCT03527251Phase 1
- Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCActive, not recruitingNCT03527108Phase 2
- Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLCStatus unknownNCT03525782Phase 1/2
- Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerTerminatedNCT03520686Phase 3
- Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong KongWithdrawnNCT03519958
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)CompletedNCT03514719Phase 1
- Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung CancerCompletedNCT03512847
- A Mobile Supportive Care App for Patients With Metastatic Lung CancerStatus unknownNCT03512015Not applicable
- A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.CompletedNCT03510611Phase 1
- Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer PatientsTerminatedNCT03509584Phase 1
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC PatientsStatus unknownNCT03504098
- Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung CancerStatus unknownNCT03502850Phase 1/2
- A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target TherapyCompletedNCT03499834Phase 2
- Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNATerminatedNCT03499678
- Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and CarboplatinWithdrawnNCT03498222Phase 1
- A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain MetastasesCompletedNCT03497767Phase 2
- Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCompletedNCT03493789Phase 1
- Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling)Active, not recruitingNCT03493581Not applicable
- Collection of Blood Samples in Patients With Non-small Cell Lung CancerTerminatedNCT03492801
- Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC PatientsStatus unknownNCT03489616Not applicable
- A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC PatientsCompletedNCT03486119
- Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung DiseaseActive, not recruitingNCT03485378Not applicable
- A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC PatientsCompletedNCT03485326
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive, not recruitingNCT03485209Phase 2
- WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLCStatus unknownNCT03481101Not applicable
- Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung CancerStatus unknownNCT03480230Phase 2
- Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical ResectionTerminatedNCT03479294
- Registry of Guardant360® Use and Outcomes In People With Advanced CancerTerminatedNCT03477474
- Study of NEO-201 in Solid Tumors Expansion CohortsActive, not recruitingNCT03476681Phase 1/2
- A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT03472053Phase 2
- Effects of Nonintubated Thoracoscopic Lobectomy on Lung ProtectionStatus unknownNCT03471884Not applicable
- ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGSCompletedNCT03465241
- Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung CancerStatus unknownNCT03461185Phase 2
- Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.TerminatedNCT03460678Phase 4
- Osimertinib as First-line Therapy for Patients With Late-stage Lung CancerStatus unknownNCT03460275Phase 2
- An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung CancerCompletedNCT03457220
- The Role of Microbiota on the Development of Lung CancerStatus unknownNCT03454685
- D-0316 First Time in Patients Ascending Dose StudyCompletedNCT03452150Phase 1
- A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung CancerCompletedNCT03451526
- Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung CancerCompletedNCT03450330Phase 1/2
- A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe ObstructionCompletedNCT03448146Phase 3
- Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.Status unknownNCT03447678Phase 2
- Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for SurgeryStatus unknownNCT03446911Phase 1/2
- Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)CompletedNCT03446547Phase 2
- A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung CancerCompletedNCT03446417Phase 1
- PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung CancerStatus unknownNCT03439215Phase 2
- Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung CancerCompletedNCT03438318Phase 1
- Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating AnesthesiaStatus unknownNCT03432637Phase 3
- Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03432156Phase 2
- Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung CancerWithdrawnNCT03431415Not applicable
- A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC PatientsCompletedNCT03429673
- A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung CancerCompletedNCT03429192
- A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung CancerCompletedNCT03427567
- A Study to Explore Prognoses of NSCLC Patients Complicated With OligometastasesStatus unknownNCT03427541
- A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase InhibitorsStatus unknownNCT03424980
- Uncommon EGFR AZD9291Status unknownNCT03424759Phase 2
- AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerCompletedNCT03421353Phase 1
- Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung CancerWithdrawnNCT03419559Phase 2
- MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLCTerminatedNCT03418532Phase 1
- An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung CancerWithdrawnNCT03417037Phase 3
- Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer RadiotherapyStatus unknownNCT03416972
- Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)Status unknownNCT03416231Phase 2
- A Study of ASN007 in Patients With Advanced Solid TumorsCompletedNCT03415126Phase 1
- An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung CancerCompletedNCT03413956
- Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral LiquidStatus unknownNCT03413358Not applicable
- Identifying the Predictive Factors of Response to PD-1 or PD-L1 AntagonistsTerminatedNCT03412058Not applicable
- Study of AGEN1884 With Pembrolizumab in 1L NSCLCTerminatedNCT03411473Phase 2
- Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR StudyActive, not recruitingNCT03410043Phase 2
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With AvelumabCompletedNCT03409458Phase 1/2
- Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
- A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT03407300Phase 2
- Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung CancerCompletedNCT03406468Phase 2
- PET CT Re-Planning NSCLC (4DCT-PET)CompletedNCT03403127Not applicable
- First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Active, not recruitingNCT03401385Phase 1
- The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR MutationStatus unknownNCT03399669Phase 2
- A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 RearrangementStatus unknownNCT03399487Phase 2
- Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung CancerStatus unknownNCT03396497Phase 1
- Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung CancerStatus unknownNCT03396185Phase 2
- TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid BiopsyCompletedNCT03394118Phase 2
- A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerActive, not recruitingNCT03392246Phase 2
- Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerActive, not recruitingNCT03391869Phase 3